Dermatology
Clinical insights on skin conditions, dermatologic procedures, and treatment approaches from practicing dermatologists.
Recent Discussions
What is your approach when a female patient does not want a male MA/scribe present in the exam room but other staff are unavailable?
I think we need to respect a patient’s request for same sex providers. Some patients are shy. For some, it is religion-based. I would ask the scribe to stand behind the curtain while I am seeing the patient. Regarding the MA, I would ask the MA to leave the room during my full-body skin exam. If I n...
How do you approach extensive recurrent genital warts that have failed liquid nitrogen, imiquimod, 5 fluorouracil and electrodessication?
I have used 0.2 ml of Candida IL with success for recalcitrant scrotal warts (injected in 2-3 lesions). I used this study below as a reference. My patient cleared in 3 sessions (4-6 weeks apart), the study below states max 5 sessions.Nofal et al., PMID 31923442
How does nemolizumab fit into your current treatment approach to prurigo nodularis relative to other biologics?
It is my first-line recommendation.
How would you approach management of a patient who develops squamous cell skin cancer while on abatacept?
I would discontinue abatacept. Several studies now have reported an increased risk of squamous cell cancer/non-melanoma skin cancers in patients on abatacept (Wadstrom et al., PMID 28975211, Simon et al., PMID 37932010) and in someone who actually develops this malignancy on the drug, I would hesita...
How would you work up a patient with cutaneous mastocytosis?
In adults, consider mastocytosis as being systemic until you prove it is not. A single normal or low-elevated tryptase does not eliminate the possibility of systemic mastocytosis. All patients should go to Heme/Onc for consideration of bone marrow biopsy and ideally high-sensitivity PCR to look for ...
How does the location or type of psoriasis affect your initial biologic choice?
Scalp and palmoplantar psoriasis are always tough. Inverse and nail psoriasis as well, but I don't find as much of a disconnect with inverse psoriasis (nb: it tends to be one of the "easier" to treat areas of psoriasis once you've made the diagnosis, evidenced by the rather stronger efficacy results...
How do you approach treatment change in patients with psoriasis who have been stable on an IL-17 or IL-23 agent but then begin to have breakthrough skin disease?
It really depends on where the patient is in their treatment journey. Patients who have tried and failed other biologics I try to optimize response by: increasing the biologic dosing frequency if insurance will allow, adding topicals, particularly newer ones like tapinarof or roflumilast, adding ph...
What is your experience managing patients with chronic spontaneous urticaria occurring only at night?
When I have patients with Chronic Spontaneous Urticaria (CSU) that is not responding like CSU should to medications, the first thing I wonder is if this is really CSU. In these situations, I will order additional lab work-up for CSU and conditions mimicking CSU, as discussed in a recent review in JA...
Are you comfortable utilizing Stelara (ustekinumab) as biologic treatment of psoriasis for patients with a history of severe latex allergy?
I don't have a lot of data to go on. On the one hand, I would be comfortable, as I doubt there would be any problem as long as the patient didn't touch the latex in the needle cover. But since we have many products without latex, perhaps it would be prudent to use those first. If other options were ...
What is the youngest age and dose that you would consider for oral minoxidil?
I would consider prescribing oral minoxidil for children as young as 2 years old, but only if the condition is severe and does not respond to topical therapy.